Ethicon Inc. and DePuy Synthes are introducing customized wound closure kits for orthopedic surgery. The new wound closure kits, which include Ethicon’s wound closure products STRATAFIX Knotless Tissue Control Devices and DERMABOND PRINEO Skin Closure System, allow for complete customization and are available through DePuy Synthes in the U.S.
Ethicon, DePuy Synthes Introduce Customized Wound Closure Kits
1 min read Premium comments
Secondary
As indicated in the March 13, 2017 news release, “…STRATAFIX Knotless Tissue Control Devices provide more strength and security, more consistency and more efficiency than traditional suture…As a replacement for sutures or staples, DERMABOND PRINEO System provides minimally invasive closure—no holes in the skin; no sutures or staples to remove, and no dressing changes, which may potentially reduce follow-up visits and support good cosmetic results for patients.”
“STRATAFIX Knotless Tissue Control Devices and DERMABOND PRINEO System also offer the additional benefits of addressing some of the risk factors associated with Surgical Site Infections (SSIs). The DERMABOND PRINEO System has been shown in vitro to provide a microbial barrier that provides protection against organisms commonly responsible for SSIs. The portfolio of STRATAFIX Knotless Tissue Control Devices offers sutures with Ethicon Plus antibacterial triclosan coating. Plus Sutures have been proven in vivo to kill bacteria on the suture known to be associated with SSIs.”
Gary Fischetti, company group chairman, North America Region, Johnson & Johnson Medical Devices Companies, told OTW, “We are creating new value for the health system by partnering across our businesses to provide efficient solutions that streamline procedures, and help improve outcomes for the millions of patients who undergo surgery each year. DePuy Synthes’ extensive reach in the orthopaedics space will enable us to bring the benefits of Ethicon’s advanced wound closure products to many more sites of care. We feel that the advanced method of closure can also lead toward improved patient satisfaction.”
“Orthopaedic surgeons are now able to choose which sutures they would like by each layer of closure, packaged in one convenient kit for specific procedures, designed to provide standardization and efficiency in the operating room. The advanced wound closure technology of STRATAFIX and DERMABOND PRINEO can also help achieve greater procedural efficiencies and optimize healing for patients.”
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.